|
End-of-day quote
Buenos Aires S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 77,225.00 ARS | +7.48% |
|
+9.15% | +9.46% |
| 10-30 | AstraZeneca: Q3 reassures investors, but valuation lacks a safety net |  |
| 10-30 | European Equities Mostly Lower in Friday Trading; BP CEO Denies Breakup Discussions | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | +7.48% | +9.15% | +9.46% | +26.08% | +1,084.80% | 290B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
